CALCIPOTRIENE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 818 adverse event reports in the FDA FAERS database where CALCIPOTRIENE was used for Psoriasis.
Most Reported Side Effects for CALCIPOTRIENE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 663 | 49.6% | 1 | 55 |
| Psoriasis | 342 | 25.6% | 0 | 12 |
| Product use in unapproved indication | 147 | 11.0% | 0 | 1 |
| Therapeutic product effect incomplete | 123 | 9.2% | 0 | 1 |
| Pruritus | 108 | 8.1% | 0 | 5 |
| Treatment failure | 102 | 7.6% | 0 | 1 |
| Skin exfoliation | 97 | 7.3% | 0 | 3 |
| Arthralgia | 81 | 6.1% | 0 | 1 |
| Erythema | 79 | 5.9% | 0 | 2 |
| Rash | 75 | 5.6% | 0 | 3 |
| Off label use | 73 | 5.5% | 1 | 13 |
| Hypertension | 66 | 4.9% | 0 | 48 |
| Diabetes mellitus inadequate control | 62 | 4.6% | 0 | 48 |
| Contusion | 60 | 4.5% | 0 | 48 |
| Skin plaque | 55 | 4.1% | 0 | 0 |
Other Indications for CALCIPOTRIENE
Product used for unknown indication (256)
Psoriatic arthropathy (43)
Morphoea (15)
Actinic keratosis (13)
Pruritus (12)
Skin cancer (10)
Eczema (8)
Precancerous skin lesion (8)
Rash (8)
Dry skin (7)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)